Journal of infection in developing countries · 2025
Salmonella-induced pericarditis.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Suranadi I Wayan, Adnyana I Komang Putra, Tarini Ni Made Adi
Аннотация
INTRODUCTION: Salmonella-induced pericarditis (SIP) is a rare complication of Salmonella infection, with only 30 cases reported to date, and a mortality rate of 14.8%. It is mostly associated with immunosuppression and can result in complications such as pericardial effusion, cardiac tamponade, and myopericarditis.
CASE PRESENTATION: A 58-year-old man complained of chest pain, cold sweats, shortness of breath, cough, and a history of fever. Physical and supporting examinations including echocardiography and pericardial fluid culture were positive for Salmonella based on VITEK 2 Biomerieux. Based on antibiotic sensitivity testing for therapy selection, the patient received 2 grams of ceftriaxone via intravenous (IV) every 24 hours which was then maximized to 2 grams every 12 hours. Outpatient management was planned after confirming the amount of pericardial fluid, last culture results, and clinical improvement.
DISCUSSION: SIP is very rare. These infections are caused by direct spread from intrathoracic foci or hematogenous spread from other sites of infection, including cross-reactivity of infectious antigens with the body`s antigens, and/or the presence of infection stimulating host immune reactions. Antimicrobials such as fluoroquinolones and third-generation cephalosporins can be given for 4-6 weeks, especially in immunocompromised individuals or those with spread to extra-intestinal sites.
CONCLUSIONS: SIP in adult patients with comorbidities and immunocompromised are associated with high morbidity and mortality. Early diagnosis, rational antibiotic therapy, and appropriate surgery provide good prognosis for patients.
CASE PRESENTATION: A 58-year-old man complained of chest pain, cold sweats, shortness of breath, cough, and a history of fever. Physical and supporting examinations including echocardiography and pericardial fluid culture were positive for Salmonella based on VITEK 2 Biomerieux. Based on antibiotic sensitivity testing for therapy selection, the patient received 2 grams of ceftriaxone via intravenous (IV) every 24 hours which was then maximized to 2 grams every 12 hours. Outpatient management was planned after confirming the amount of pericardial fluid, last culture results, and clinical improvement.
DISCUSSION: SIP is very rare. These infections are caused by direct spread from intrathoracic foci or hematogenous spread from other sites of infection, including cross-reactivity of infectious antigens with the body`s antigens, and/or the presence of infection stimulating host immune reactions. Antimicrobials such as fluoroquinolones and third-generation cephalosporins can be given for 4-6 weeks, especially in immunocompromised individuals or those with spread to extra-intestinal sites.
CONCLUSIONS: SIP in adult patients with comorbidities and immunocompromised are associated with high morbidity and mortality. Early diagnosis, rational antibiotic therapy, and appropriate surgery provide good prognosis for patients.